Guangkang Biochemical (300804.SZ): The company's chloramphenicol products have not been put into production

Zhitongcaijing · 06/09 14:49

According to the Zhitong Finance App, Guangkang Biochemical (300804.SZ) issued an announcement. The cumulative deviation value of the company's stock closing price increase exceeded 30% for three consecutive trading days from June 5, 2025 to June 9, 2025. According to the relevant provisions of the “Shenzhen Stock Exchange Trading Rules”, this is an abnormal fluctuation in stock trading. The cumulative deviation value of the closing price increase of the company's stock exceeded 100% for nine consecutive trading days from May 27, 2025 to June 9, 2025. According to the relevant provisions of the “Shenzhen Stock Exchange Trading Rules”, this is a serious abnormal fluctuation in stock trading.

Recently, investors have paid close attention to the production capacity and progress of the company's chloramphenol products. The company now explains the relevant matters as follows: The company's EIA design production capacity is 10 tons/year. Currently, the product has not been put into production. After completing the relevant production process, it is expected that the product will contribute less to the company's overall performance.